SANA FY 2020 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$10M

Operating Income

-$161M

Net Income

-$285M

EPS (Diluted)

$-1.63

Cash Flow

Operating Cash Flow

-$138M

Free Cash Flow

-$162M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$730M

Total Liabilities

$1.2B

Stockholders' Equity

-$421M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$10M	-$4M	-159.4%
Operating Income	-$161M	-$141M	-14.1%
Net Income	-$285M	-$131M	-118.2%